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Abstract: The assessment of endothelial function as brachial artery ﬂ  ow-mediated vasodilatation 
is a widely used technique that determines the effect of risk factor intervention and may have 
the potential to predict the clinical beneﬁ  t of antiatherogenic therapy. Previous studies suggest 
that ﬂ  ow-mediated dilation is greater using the upper-arm occlusion technique, but no data are 
available to compare intertester reliability between technicians. This study was undertaken to 
compare the amount of hyperemia between upper and lower occlusion techniques and to deter-
mine reproducibility between testers. Nineteen healthy adults, ages 25 to 50, were included in the 
study. Brachial artery vasodilatation was measured 1 and 3 minutes post cuff deﬂ  ation and was 
compared with the baseline and expressed as a percent change. There was a tester effect in the 
percent change in diameter across all measurements. The results of this study reveal inconsisten-
cies between testers when using a blood pressure cuff to induce hyperemia for the assessment of 
endothelial function through brachial artery ﬂ  ow-mediated vasodilation. However, upper arm as 
compared to lower arm blood pressure cuff occlusion results in signiﬁ  cantly greater hyperemia 
and vasodilatation, even though there was a difference in measurements between testers.
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Over the past decade, a noninvasive technique has evolved to evaluate ﬂ  ow-mediated 
vasodilatation (FMD), an endothelium-dependent function, in the brachial artery 
(Anderson and Mark 1989; Laurent et al 1990; Celarmajer et al 1992; Sorensen et al 
1995). This noninvasive procedure utilizes high resolution ultrasound imaging in 
which brachial arteries are scanned under baseline conditions and during hyperemia 
(Bots et al 2005). Induction of hyperemia occurs through the inﬂ  ation and deﬂ  ation of 
a sphygmomanometer (blood pressure) cuff, with the occlusion located either at the 
lower or upper arm and generally lasts 5 minutes before deﬂ  ation (Bots et al 2005). 
Endothelial function, which through ﬂ  ow-mediated vasodilatation is expressed as 
a percentage change in diameter of vessels from baseline conditions to maximum 
diameter during hyperemia, is abnormal in the presence of coronary risk factors and 
coronary artery disease, and might be an important initiating factor in the pathogen-
esis of arteriosclerosis (Glasser et al 1996; Celermajer 1997; Vogel et al 2000; Bots 
et al 2005). The assessment of endothelial function as brachial artery ﬂ  ow-mediated 
vasodilatation is also important to determine the effect of risk factor intervention and 
may have the potential to predict the clinical beneﬁ  ts of antiatherogenic therapy. Bots 
and colleagues (2005) conducted a literature review in which they “evaluated techni-
cal and operative factors and their relationship to the variety in absolute values of 
ﬂ  ow-mediated vasodilatation across studies published between 1992 and 2001” (Bots 
et al 2005, p 364). They concluded that the technical aspects, which they described as Vascular Health and Risk Management 2008:4(3) 732
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location and duration of the occlusion, potentially explain 
the variability between and within previous studies utilizing 
this technique (Bots et al 2005). Additionally, two reports 
suggested that the percent change in ﬂ  ow-mediated vasodi-
latation is greater using the upper arm occlusion technique 
versus the lower arm occlusion (Mannion et al 1998; Vogel 
et al 2000). While previous studies suggest variability in the 
technical aspects, no data are available to compare intertester 
reliability between technicians. Therefore, we studied the 
reproducibility of brachial artery reactivity in different sub-
jects under several conditions. Both upper and lower arm cuff 
inﬂ  ation methods were examined by two different certiﬁ  ed 
testers with equal experience. This study was undertaken to 
compare the amount of hyperemia between upper and lower 
occlusion techniques and to determine reproducibility of 
measurements between testers.
We studied 19 healthy adults (7 men and 12 women aged 
25 to 50 years) without risk factors other than age and gender 
(eg, males over the age of 45). These subjects had serum 
cholesterol  200 mg/dl, blood pressure  132/90 mmHg 
(off medications), no history of cigarette smoking or diabetes 
mellitus, and none were taking vasoactive medications at the 
time of this study.
Each technician performed two upper and two lower 
occlusions per subject on separate occasions, and all scans 
were completed within four weeks. Flow-mediated vasodi-
latation was assessed between 8:00 and 10:00 A.M. at the 
Endothelial Function Laboratory at Hartford Hospital. Sub-
jects were asked to refrain from consuming stimulants such as 
caffeine, which might have an effect on endothelial function, 
for 24 hr before the testing session. Subjects were also asked 
to fast overnight (approximately 12 hours) before each scan 
and refrain from using Sildenaﬁ  l (Viagra, which might have 
a vasoactive effect and can react with the nitroglycerin pills 
used during the brachial artery reactivity assessment). All 
subjects included in the study provided informed consent 
as approved by the Institutional Review Board of Hartford 
Hospital and were measured a total of four times by two 
different technicians.
Endothelial function was determined using high-
resolution ultrasound of the brachial artery and ischemic 
forearm occlusion. For this procedure, subjects rested for 10 
minutes in the supine position. ECG leads were attached to 
monitor heart rate and for image acquisition. Images were 
acquired in correspondence of the R wave of the ECG. A 
baseline blood pressure was taken in the left arm. The right 
brachial artery was imaged for a baseline measurement two 
inches above the antecubital fossa using an Acuson Aspen 
ultrasonography machine (Acuson Corp, Mountain View, 
CA, USA). A Hokanson Rapid Cuff Inﬂ  ator (DE Hokanson 
Inc, Bellevue, WA, USA) was placed over the right forearm, 
below the elbow for lower occlusion and below the axillary 
for upper occlusion. The cuff was inﬂ  ated 60 mmHg above 
the resting systolic pressure for 5 minutes. The occluding 
pressure was released and the artery imaged 1 and 3 minutes 
post deﬂ  ation. Following the endothelial dependent assess-
ment, the subject rested for 15 minutes to allow the effects 
of cuff occlusion to reside. A second baseline measurement 
was taken following the 15-minute rest period. A physician or 
nurse administered 0.4 mg of sublingual nitroglycerin to the 
subject. Nitroglycerin was used to show independent vaso-
dilatation on the smooth muscle of the artery. Vessel diam-
eter was recorded 3 and 5 minutes following nitroglycerin 
administration. Blood pressure of the subject was monitored 
in the supine, seated, and standing positions following the 
ultrasound for possible hypotensive response. Arterial cross-
sectional diameter was measured from the near endothelial-
luminal surface to the distal luminal surface. Endothelial 
function was quantiﬁ  ed as the percent change in brachial 
artery diameter (vasodilatation) by dividing the change in 
diameter by the baseline value after 1, 3, and 5 minutes of 
lower and upper arm ischemic occlusion.
Descriptive statistics were calculated for anthropometrics 
and dependent variables (Table 1). A 2 x 2 repeated ANOVAs 
was used to analyze the data. Technician, (Tester 1 versus 
Tester 2), an independent groups factor, and position (upper 
and lower), a repeated measures factor, were the independent 
variables. The dependent variables were the percent change 
in dependent and independent endothelial dilatation. Sidak 
post hoc comparisons were conducted following signiﬁ  cant 
interactions. A level of p  0.05 was considered statistically 
signiﬁ  cant.
The results indicated the effects of position and technician 
on reactivity. As expected, upper arm occlusion resulted in 
a signiﬁ  cantly greater (p  0.05) percent change in dilation 
at 1 minute and 3 minutes post occlusion when compared 
to lower-arm occlusion, regardless of the tester (9.52 and 
Table 1 Age and anthropometric measurements in the subject 
group (N = 19) (mean ± SD)
Variables Mean  ± SD
Age (years)  36.75 ± 7.92
Height (m)  1.70 ± 11.72
Weight (kg)  73.27 ± 21.83
BMI (kg/m2) 25.33  ± 7.44
Abbreviations: BMI, body mass Index; SD, standard deviation.Vascular Health and Risk Management 2008:4(3) 733
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9.32 versus 6.7 and 4.32% at 1 minute post occlusion; 7.5 and 
8.3 versus 4.9 and 1.9% at 3 minutes post occlusion). Cuff 
placement did not affect the response to NTG (p  0.05).
For both testers, upper arm cuff placement resulted in 
a greater percent change at 1 minute and 3 minutes when 
compared with lower arm cuff placement. There was a tester 
effect in percent change diameter across all measurements 
(post occlusion at 1 minute and 3 minutes; post NTG at 
3 minutes and 5 minutes) (Tables 2 and 3). Tester 2 recorded 
signiﬁ  cantly (p  0.05) higher percent changes in diameter 
in the upper occlusion than Tester 1 (6.7 versus 4.3%).
Since the inception of the description of brachial artery 
ﬂ  ow-mediated vasodilatation via ultrasound by Anderson and 
Mark (1989), several studies have utilized the technique for a 
variety of purposes. Some studies have reported greater vaso-
dilatation employing upper arm versus lower arm occlusion in 
the same subjects (Sorensen et al 1995; Mannion et al 1998). 
Although upper arm cuff occlusion was initially used as the 
hyperemic stimulus, several laboratories and technicians 
changed to lower arm occlusion, because it caused less patient 
discomfort, and it was easier to visualize the brachial artery 
during and immediately after cuff deﬂ  ation (Mannion et al 
1998). In addition, concerns were raised regarding whether 
the upper arm approach produced “ischemic” vasodilatation 
in addition to ﬂ  ow-mediated vasodilatation.
This study found that 5 minutes of upper arm cuff occlu-
sion produced signiﬁ  cantly more brachial artery hyperemia 
than lower arm cuff occlusion. Additionally, there was a 
difference between testers for the upper arm occlusion, as 
one tester recorded higher percent changes in the upper 
arm occlusion position. The difference found in upper arm 
occlusion values in this study between testers could be due 
the more challenging upper arm occlusion technique. It 
has been demonstrated that accurate data acquisition of the 
upper arm is technically more challenging since the image 
is distorted by a collapse of the brachial artery and a shift of 
tissue (Corretti et al 1995).
In the present study, both testers were trained in the prin-
ciples and technical aspects of 2D and Doppler ultrasonog-
raphy, but it has been observed that there is a learning curve 
that requires several months and depends on the technical 
skills of the individual and the frequency with which the tech-
nique is performed (Corretti et al 1995, 2002). Meticulous 
attention to detail is necessary since small shifts in the angle 
of approach in the ultrasound beam may alter the diameter 
measurements substantially.
It is entirely plausible that a change in the hyperemic 
stimulus could also contribute to differences observed 
between testers. When the cuff is placed on the upper part of 
the arm, reactive hyperemia typically elicits a greater percent 
change in diameter compared with that of lower arm cuff-
placement. The greater hyperemia observed in the upper-arm 
occlusion might be due to a greater ﬂ  ow stimulus resulting 
from recruitment of more resistance vessels. The ﬂ  ow stimu-
lus should be consistent since any change in dilatation of the 
conduit artery may be related to changes in ﬂ  ow rather than 
improvement in vessel dilatation. A minimal difference in 
cuff placement for the upper occlusion between testers in 
the present study might have accounted for the different 
measurements observed.
Our study demonstrates that upper arm compared to 
lower arm blood pressure cuff occlusion when undertaken 
to induce hyperemia for the assessment of brachial artery 
ﬂ  ow-mediated vasodilatation results in signiﬁ  cantly greater 
hyperemia. While other studies have revealed similar results, 
our study is the ﬁ  rst to compare intertester reliability of 
assessment in both cuff positions. The variability and incon-
sistencies in absolute values between previous studies have 
been displayed as due to technical aspects, such as the loca-
tion and duration of the occlusion (Bots et al 2005). In our 
Table 2 Comparison of upper versus lower arm occlusion 
between testers (dependent dilatation)
 Tester  1  Tester  2
Baseline absolute diameter (mm)
Upper occlusion  3.67 ± 0.55  3.5 ± 0.70
Lower occlusion  3.83 ± 0.88  3.6 ± 0.68
Percent change diameter (%)
Upper 1-min post occlusion (%)  9.52 ± 4.25*  9.36 ± 6.15*
Lower 1-min post occlusion (%)  6.68 ± 4.03  4.32 ± 3.38
Upper 3-min post occlusion (%)  7.51 ± 4.47*  8.33 ± 7.90*
Lower 3-min post occlusion (%)  4.86 ± 4.06  1.87 ± 2.65
Notes:   Values are means ± SD. *p  0.05 vs. baseline.
Table 3 Comparison of upper versus lower arm occlusion 
between testers (independent dilatation)
 Tester  1  Tester  2
Baseline 2 absolute diameter (mm)
Upper occlusion  3.71 ± 0.62  3.73 ± 0.86
Lower occlusion  4.07 ± 1.11  3.67 ± 0.83
Percent change diameter (%)
NTG upper 3-min post occlusion (%)  18.40 ± 5.88*  17.78 ± 8.13*
NTG lower 3-min post occlusion (%)  14.90 ± 5.24  16.80 ± 7.14
NTG upper 5-min post occlusion (%)  21.67 ± 5.42*  17.26 ± 8.01*
NTG lower 5-min post occlusion (%)  17.97 ± 5.62  19.69 ± 6.18
Abbreviation: NTG, nitroglycerin.
Notes: Values are means ± SD. *p  0.05 vs. baseline.Vascular Health and Risk Management 2008:4(3) 734
Cosio-Lima et al
study, the greater hyperemia using upper arm cuff placement 
is shown as independent of testers. However, there were 
differences in post occlusion measurements between tes-
ters, and this suggests that regardless of techniques used, 
interpretation of ultrasound measurements require adequate 
training and technique skills. Although higher dilatation 
responses with the upper arm occlusion occur regardless 
of the tester, we recommend that intertester variability in 
image acquisition and analysis be periodically reassessed, 
as intertester variability might be a causative factor in the 
great variation between absolute values of ﬂ  ow-mediated 
vasodilatation across studies. We studied a healthy popula-
tion, but as endothelial function is central in determining 
prognosis and treatment interventions in several special 
populations (eg, coronary heart disease and diabetes mel-
litus), it is of paramount importance that all technicians 
acquire the skills and training necessary to obtain accurate 
assessments. Future research needs to be conducted to evalu-
ate intertester reliability in ﬂ  ow-mediated vasodilatation in 
upper and lower arm occlusion and might consider using a 
special population.
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